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Does your child have reflux or could there be more to it than that
Cody R. Elam, RN
Otterbein University, Westerville, Ohio
Underlying Pathophysiology.
Eosinophilic esophagitis (EE) is
differentiated from Gastroesophageal
Reflux Disease (GERD) by endoscopic
and histopathologic examination. The
hallmark of EE is eosinophilic infiltration
of the esophagus. EE has been defined as
“a clinicopathologic entity, combining
clinical data on (1) relevant symptoms
(distinct in the pediatric or adult
populations with mostly food impaction
and dysphagia in adults and feeding
intolerance, failure to thrive, and GERD
symptoms in children); (2) esophageal
biopsies with adequate histologic
findings in the esophageal biopsies (>15
eosinophils/high power field [HPF]); and
(3) exclusion of other diseases with
overlapping features, especially GERD”
(Genevay, Rubbia-Brandt, & Rougemont,
2010, p.816).
Under normal circumstances, the
esophageal mucosa is devoid of resident
eosinophils, however there are certain
disease states in which eosinophils
infiltrate into and accumulate within the
esophageal mucosa. EE and GERD are
two of these disease states, with lower
numbers of infiltrating eosinophils in
GERD, and more numerous eosinophils in
EE.
Although the etiology of EE is not
fully established, for whatever reason
there is an infiltration/migration of
eosinophils into the esophageal mucosa.
There is strong evidence that points
towards an IgE-mediated allergic
reaction, with the offending agent being
either a food allergen or an aeroallergen
(inhaled). There also seems to be a
correlation between asthma and EE, as
evidenced by the high numbers of EE
patients who also suffer from asthma.
The effects that eosinophils play on
the esophageal mucosa are multiple. In
general, the effects are proinflammatory
and include the upregulation of adhesion
systems, and the mediation of cell
trafficking through the release of various
cytokines, chemokines, and lipid
mediators. The tissue damage and
dysfunction that results from the release
of cationic proteins results in fibrosis of
the esophagus. Toxic granule proteins
are released that cause further mast cell
degranulation, resulting in a vicious cycle
of inflammation and tissue damage
(Swoger, et al, 2007, p.1542).

Swoger, et al have proposed a
method of eosinophil recruitment to
the normally eosinophil-devoid
esophagus involving interleukin(IL) 5
and procedes as such: The cytokine
IL-5, produced by T-helper type II
lymphocytes primes eosinophils to
react to chemoattracts such as
eotaxin. IL-5 also promotes the
eosinophil’s development, as well as
activation, migration, and effector
functions. Furthermore, IL-5 is
overexpressed, and this systemic
overexpression may directly promote
migration of the eosinophils to the
esophagus. The presence of an
increased number of mast cells and T
cells in the esophagus of EE patients
has also been documented (Swoger,
et al, 2007, p.1543). Eotaxin
promotes eosinophil accumulation
and adhesion to the esophageal
endothelium by way of vascular cell
adhesion molecule (CAM) 1, present
on the surface of endothelial tissues
and has also been found to be
overexpressed in patients with EE
(Swoger, et al, 2007, p.1543)
Another cytokine, cytokine IL-13,
which upregulates IgE, is important
for eosinophil survival, and activates
adhesion systems also plays a role.
Studies have proven a dysregulation
of IL-13 in several allergic disorders
such as asthma, atopic dermatitis,
and allergic rhinitis (Swoger, et al,
2007, p.1543). This lends credibility
to the proposed link between EE and
an allergic (IgE-mediated)
provocation.
To lend further evidence to the
allergy-associated theory, it has been
reported that “approximately 80% of
pediatric patients with EE had a
positive skin test result to a panel of
food allergens and aeroallergens”
(Swoger, et al, 2007, p.1543).
It is important to note, however,
that a direct correlation does not
always exist between a positive food
allergy test result and the
development of EE. Some patients
continue to have symptoms even
after foods that were positive on
traditional allergy testing are
eliminated (Swoger, et al, 2007,
p.1543).

Several foods have been identified
as being most-problematic for
patients with EE. These foods are
rich in protein and the classic
examples include: milk, eggs, soybeans, corn, wheat, chicken, and nuts
(Swoger, et al, 2007, p.1543). Recall
the patient in the case study who
failed to show a positive response to
a soy-based formula.
It is important to note, however,
that the provoking allergen, whether
food or aeroallergen may not be a
pure IgE mediated reaction and that
not all allergens are identifiable by
traditional skin-prick testing. For
this reason, EE has been described
by some as a polygenic allergy
disorder. Signs of an IgE-mediated
allergic reaction, such as type-I
histamine-mediated reactions (in
which a reaction occurs within
minutes of exposure to the allergen),
may coexist with a delayed
hypersensitivity reaction that may
occur hours to days after the
exposure to the offending antingen
(Swoger, et al, 2007, p.1543).
Inhaled (aero) allergens are
thought to play a role in the
infiltration of the esophageal mucosa
as well, as pulmonary exopsure to
these inahled antigens may result in
esophageal mast cell activation,
resulting in the release of cytokines
that further activates the
inflammatory response. Additionaly,
the aeroallergens may be swallowed
after being transported from the
lung to the oropharynx by a ciliary
mechanism where they can then
provoke cytokine production in the
esophagus.
The combined data on both food
and aeroallergens “suggest 2
possible mechanisms of disease in
EE. There might be initial
sensitization due to a food antigen,
with EE occurring on esophageal rechallenge with the same antigen.
Alternatively, there might be initial
bronchial sensitization followed by
esophageal rechallenge” (Swoger, et
al, 2007, p. 1454).

A Case Study: Eosinophilic Esophagitis vs
GERD in children
A 4 month old girl presents with colic,
feeding irritability and copious vomiting
that is refractory to H2R antagonists
(Zantac), as well as dietary changes from
breast milk to a soy-based formula.
Medical history at time of presentation
includes URI and asthma (wheezing). At
age 6 months, she is switched from
Zantac to Prevacid, and formula is
switched to one with pre-digested milk
proteins. During this time, a slow, yet
steady improvement in feeding habits
and a reduction in the amount of
vomiting are noticed, yet symptoms do
persist.

Gastroenterology referral is made at the
1 year mark but an appointment cannot be
made for another 6 months. During this
time, subtle improvements are made
through the dietary elimination of all milk
products but signs of reflux still persist (i.e.
vomiting and slow weight-gain). By two
years of age, the toddler undergoes an
esophagogastroduodenoscopy to rule out
other causes of her GI symptoms.
Treatment continues with PPI (Prevacid)
until the patient is 4 years of age, at which
she is weaned from pharmacologic agents
and exhibits resolution of GI symptoms.

Significance of
Pathophysiology
As the pathophysiology of EE
demonstrates a strong relationship
between either food, or aeroallergens,
prompt recognition of the offending
allergen is crucial. The multi-faceted
complications from this disease require a
multi-disciplinary approach, which
should consist of: gastroenterologist
consultation, along with consultation
from both a dietician and a specialist in
allergy/immunology. Once an individual
is diagnosed with EE, every effort must
be made to identify the offending
allergen. Dietary management then
becomes a major focus of treatment.
Known as the “six food elimination diet”,
the removal of the six most common
allergenic foods (milk, soy, egg, wheat,
peanut/tree nuts, fish/shellfish) has
shown a promising effect on the
symptomatic relief of patients with EE.
According to a study found in
Contemporary Pediatrics, 74% of
patients with EE showed histopathologic
improvements after implementation of
the six food elimination diet (Schuval &
Gold, 2013, p.17). If diagnosed and
properly treated in a timely manner, the
long term sequelae caused from EE such
as esophageal strictures and smallcaliber esophagus may be avoided.

Histopathologic slide showing eosinophilic infiltration of esophageal tissue.

Sign and Symptoms of Eosinophilic
Esophagitis in Children
•Nausea
•Recurrent Vomiting
•Weight Loss
•Failure to Thrive
•Anemia
•Choking
•Feeding Disturbances
•Irritability
•Abdominal Pain

*Note the multiple overlaps that
correlate with the symptoms of
Gastroesophageal Reflux Disease.

Top: barium swallow showing
esophageal strictures in EE.
Bottom: endoscopic image
showing trachealization of the
esophagus in EE.

Implications for
Nursing Care
Eosinophilic esophagitis is a chronic
disease with long-term persistence of
esophageal inflammation (Schuval &
Gold, 2013, p. 20). Timely recognition
and diagnosis is key to reducing the
impact that long-term irritation by
eosinophilic infiltration plays on the
esophagus. As nurses are very often on
the front-line of history taking and
information gathering on a patient, it is
important to recognize the signs of
reflux-like symptoms that are either
refractory to, or slow to respond to
traditional reflux therapies (such as the
use of PPIs). Many times, nurses for
whatever reason are privy to information
that is not always divulged from the
patient to the primary care giver. Careful
analysis of provoking/relieving factors
must be made.

Conclusion
Although the symptoms of GERD
are shared by those of eosinophilic
esophagtitis, for the most part, the
resemblances stop here. Treatment of
GERD is largely focused on the
pharmacologic use of PPIs and H2R
antagonists. EE is in large part
refractory to these agents. Treatment
modalities for EE are labor-intensive
and require a multi-disciplinary team
of gastreoenterologists, allergists, and
dieticians for effective management.
Prompt recognition and early
treatment of EE vs. GERD leads to an
overall improvement in the quality of
life of an individual with EE. The
saying “time is tissue”, although
routinely used in terms of a cardiac
setting, also very much so applies to
eosinophilic esophagitis.
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